Harvard study: NFL should offer treatment for performance-enhancing drug users
From the Boston Globe:
The National Football League should consider providing treatment to any player caught using performance-enhancing drugs, according to a new Harvard University study.
The recommendation was one of several put forward by researchers from the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.
Their study, entitled “Comparing Health-Related Policies and Practices in Sports: The NFL and Other Professional Leagues,” is aimed at improving player health, the researchers wrote in a 12-page executive summary.
“NFL football has a storied history and holds an important place in this country,” the authors wrote, while noting the NFL is the top-grossing pro sports league in the United States with 2017 revenues expected to reach $14 billion. “The men who play it deserve to be protected and have their health needs met and it is our fervent hope that they will be met.”
The study examined health policies of the NFL, Major League Baseball, National Basketball Association, National Hockey League, Canadian Football League, and Major League Soccer. [...]
Download the Football Players Health Study Law & Ethics Initiative's full report, "Comparing Health-Related Policies & Practices in Sports: The NFL and Other Professional Leagues," now!bioethics football players health study holly fernandez lynch i. glenn cohen regulation